00310-4535 IMJUDO - CanMED: NDC

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Product Information

CanMED: NDC

Product NDC:

00310-4535

Brand Name:

IMJUDO

Generic Name:

Tremelimumab

Dosage Form Name:

INJECTION, SOLUTION

Administration Route:

Intravenous

Substances:

Name: TREMELIMUMAB

Strength: 300.0

Unit: mg/15mL

Packages:

Code: 00310-4535-30

Description: 1 VIAL in 1 CARTON (0310-4535-30) / 15 mL in 1 VIAL

Effective Date: Oct. 21, 2022

Discontinued:

SEER*Rx Category:

Immunotherapy

Major Class:

Monoclonal Antibody

Minor Class:

CTLA-4

Orphan Drug Designation:

Yes

Status:

In Use